Katja Eschbach

Katja Eschbach is a skilled scientist with extensive experience in the biotechnology and pharmaceutical sectors. Currently serving as Principal Associate Scientist at Skyhawk Therapeutics since August 2019, Katja previously worked as Senior Research Associate. Prior experience includes roles at ETH Zürich from June 2012 to July 2019, where responsibilities included serving as Lab Specialist in Single-Cell Genomics and working at the Genetic Diversity Centre. Additionally, Katja held the position of Scientific Associate in the MSD Department at Novartis Institutes for BioMedical Research for a year and was a Research Associate/Lab Specialist at Roche from September 2002 to June 2011.